touchPANEL DISCUSSION for touchNEUROLOGY
Listen to a panel of leading multiple sclerosis (MS) experts discuss their perspectives on the benefits of disease-modifying therapies (DMTs) in MS, and current approaches to treatment sequencing.
The experts
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent educational grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchneurology.com/cme/treatment-sequencing-in-ms-the-benefits-of-dmts/
Haemato-oncology experts discuss managing the practicalities of CAR T-cell therapy in relapsed or refractory follicular lymphoma
Haemato-oncology experts discuss managing the practicalities of CAR T-cell therapy in relapsed or refractory follicular lymphoma
Advances in IOL technology and power calculations: Updates and innovations
Guideline-based treatment of recurrent/metastatic cervical cancer
IgG4-related disease: How to identify, diagnose and treat
Paediatric atopic dermatitis: Evolving strategies for improved management
Paediatric atopic dermatitis: Evolving strategies for improved management
Optimizing the management of patients with relapsing forms of MS: An update on emerging treatment options
Cataract surgery and ocular comorbidities: Key considerations for intraocular lens choice
PSMA-targeted radiopharmaceuticals: An evolving approach to prostate cancer management
Clinical care pathway for Alzheimer’s disease Driving improvements in diagnosis
Using anti-CGRP antibodies for migraine prevention: Key learnings
Treatment of endometrial cancer: Highlights from ESGO 2023
Practical considerations for personalized medicine in thyroid cancer: Which therapies are suited to particular patient profiles?
Practical considerations for personalized medicine in thyroid cancer: Which therapies are suited to particular patient profiles?
Personalized therapy for NSCLC: Biomarker testing, treatment and management in the presence of MET alterations
Personalized therapy for NSCLC: Biomarker testing, treatment and management in the presence of MET alterations
COVID-19 vaccination: What have we learned and what more can we do to address vaccine inequity in the Middle East?
COVID-19 vaccination: What have we learned and what more can we do to address vaccine inequity in Africa?
The mRNA vaccine platform: A novel tool for the rapid development of vaccines against respiratory viral infections
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
The Psychic Elephant Radio Podcast
Museum of the Missing
Sasquatch Chronicles
Hidden Brain